Addex Therapeutics (ADDXF) News Today → 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad) Free ADDXF Stock Alerts $0.99 0.00 (0.00%) (As of 02/3/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAddex Therapeutics earnings: here's what to expectmarkets.businessinsider.com - March 24 at 11:33 AMAddex Therapeutics Ltd (ADXN)investing.com - March 22 at 9:03 AMADRs Close Higher; Addex Therapeutics Climbs 21%morningstar.com - January 25 at 8:04 PMAddex Therapeutics is about to announce its earnings — here's what to expectmarkets.businessinsider.com - November 28 at 10:36 AMAddex Announces Plan to Implement ADS Ratio Changebenzinga.com - October 6 at 5:14 PMAddex mGlu2 NAM Cognition Program Receives €4 Million Grantmarkets.businessinsider.com - September 20 at 3:27 AMAddex's Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Braintmcnet.com - September 4 at 7:23 AMAddex mGlu2PAM Demonstrates Potential in Substance Use Disorderbenzinga.com - July 24 at 8:21 AMAddex Therapeutics Q1 EPS $(0.04) Up From $(0.97) YoY, Sales $542.43K Up From $264.20K YoYbenzinga.com - May 12 at 8:18 PMAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Studybenzinga.com - May 10 at 3:22 AMAddex Therapeutics: Addex Completes $5.0 Million Equity Financingfinanznachrichten.de - April 5 at 8:46 AMAddex Completes $5.0 Million Equity Financingbenzinga.com - April 5 at 8:46 AMAddex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson's Diseasetmcnet.com - April 4 at 2:28 AMAddex Therapeutics FY22 Loss Widens, Income Downmarkets.businessinsider.com - March 30 at 2:25 AMAddex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Whybenzinga.com - June 17 at 7:52 AM Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADDXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide ADDXF Media Mentions By Week ADDXF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADDXF News Sentiment▼0.000.49▲Average Medical News Sentiment ADDXF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADDXF Articles This Week▼00▲ADDXF Articles Average Week Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADDXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BAYRY News Today CAPS News Today CNTX News Today IMUC News Today GNMSF News Today GRFS News Today HYPMY News Today IMVIQ News Today ISCO News Today MYNZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ADDXF) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressBiden’s $374B Giveaway Into This SectorDTIA.I. Pioneer Issues Urgent Warning to AmericansTradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.